Eukaryotic translation initiation factors in cancer development and progression
- 1 October 2013
- journal article
- review article
- Published by Elsevier BV in Cancer Letters
- Vol. 340 (1), 9-21
- https://doi.org/10.1016/j.canlet.2013.06.019
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMPEuropean Journal of Medicinal Chemistry, 2010
- Transforming growth factor beta (TGF-β) and inflammation in cancerCytokine & Growth Factor Reviews, 2010
- eIF1 Controls Multiple Steps in Start Codon Recognition during Eukaryotic Translation InitiationJournal of Molecular Biology, 2009
- The eIF3 Interactome Reveals the Translasome, a Supercomplex Linking Protein Synthesis and Degradation MachineriesMolecular Cell, 2009
- Archaeal aIF2B Interacts with Eukaryotic Translation Initiation Factors eIF2α and eIF2Bα: Implications for aIF2B Function and eIF2B RegulationJournal of Molecular Biology, 2009
- Bridging IRES elements in mRNAs to the eukaryotic translation apparatusBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2009
- Topology and Regulation of the Human eIF4A/4G/4H Helicase Complex in Translation InitiationCell, 2009
- Loss of the eukaryotic initiation factor 3f in melanomaMolecular Carcinogenesis, 2008
- The initiation factor eIF3-f is a major target for Atrogin1/MAFbx function in skeletal muscle atrophyThe EMBO Journal, 2008
- Loss of the eukaryotic initiation factor 3f in pancreatic cancerMolecular Carcinogenesis, 2007